The Pharmaceutical Market: USA

Date: January 31, 2013
Pages: 107
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PB69D0286E2EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: USA
OVERVIEW OF THE PHARMACEUTICAL MARKET IN THE USA

Despite assertions from some stakeholders, the r e-election of Barack Obama as President of the United States is not bad news for pharmaceutical companies and medical device manufacturers, primarily because we expect continuation of existing policies that have generally been favourable. However, we caution that further reforms to the he althcare sector are inevitable, due to unsustainable spending on medical services, by both the public and private sectors.

Headline Expenditure Projections:

Pharmaceuticals: US$337.1bn in 2011 to US$343.1bn in 2012; +1.3% growth in local currency terms. Forecast slightly down from Q4 12.

Healthcare: US$2,708bn in 2011 to US$2,844bn in 2012; +5.0% growth in local currency terms. Forecast slightly down from Q4 12.

Medical devices: US$133bn in 2011 to US$138bn in 2012; +4.6% growth in local currency terms. Forecast slightly down from Q4 12.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    US Pharmaceuticals And Healthcare Industry SWOT
    United States Political SWOT
    United States Economic SWOT
    United States Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Americas Pharmaceutical Risk/Reward Ratings, Q113
    Rewards
    Risks

US – MARKET SUMMARY

REGULATORY REGIME

    Innovative Drug Regulations
    Prescription Drug User Fee Act (PDUFA)
    Generic Drug Regulations
    Biosimilar Regulations
    OTC Medicine Regulations
    Medical Device Regulations
    Promotion Regulations
    Intellectual Property Regulations
    Pricing And Reimbursement Environment
    Part D

INDUSTRY DEVELOPMENTS

    Epidemiology
    Healthcare Sector
    Research & Development Sector
    Clinical Trials
    Contract/Clinical Research Organisations
    Medical Device Industry
    Hospital Sector

INDUSTRY FORECAST SCENARIO

    Pharmaceutical Market Forecast
    Table: Pharmaceutical Sales Indicators 2008-2016
    Key Growth Factors – Industry
    Table: Healthcare Expenditure Indicators 2008-2016
    Table: Healthcare Governmental Indicators 2008-2016
    Table: Healthcare Private Indicators 2008-2016

MACRO CHART PACK - NOMINAL GROWTH PICKING UP PACE

    Table: Macro Indicators
    Prescription Drug Market Forecast
    Table: Prescription Drug Sales Indicators 2008-2016
    Table: Top 10 Therapeutic Classes By Sales (US$bn)
    Table: Top 10 Therapeutic Classes By Dispensed Prescriptions (mn)
    Patented Drug Market Forecast
    Table: Patented Drug Market Indicators 2008-2016
    Generic Drug Market Forecast
    Table: Generic Drug Sales Indicators 2008-2016
    OTC Medicine Market Forecast
    Table: OTC Medicine Sales Indicators 2008-2016
    Medical Device Market Forecast
    Table: Medical Devices Sales Indicators 2008-2016
    Pharmaceutical Trade Forecast
    Table: Exports and Imports Indicators 2008-2016
    Key Risks To BMI's Forecast Scenario

COMPETITIVE LANDSCAPE

    Research-Based Industry
    Table: Top 10 Companies By US Prescription Sales (US$bn)
    Table: Top 10 Drugs By US Sales (US$bn)
    Research-Based Industry – Key Developments
    Generic Drugmakers
    Table: Top 10 Companies By US Dispensed Prescriptions (mn)
    Drug Distribution Sector
    Pharmacy Retail Sector
    Table: US Dispensed Prescription Drug Distribution By Channel Distribution Volume (mn)

COMPANY PROFILES

  US Companies
    Pfizer
    Merck & Co
    Eli Lilly
    Amgen
    Watson Pharmaceuticals
  Foreign Companies
    GlaxoSmithKline
    AstraZeneca

DEMOGRAPHIC OUTLOOK

    Table: Population By Age Group, 1990-2020 ('000)
    Table: Population By Age Group, 1990-2020 (% of total)
    Table: Key Population Ratios, 1990-2020
    Table: Rural And Urban Population, 1990-2020

GLOSSARY

BMI METHODOLOGY

    How We Generate Our Pharmaceutical Industry Forecasts
    Pharmaceuticals Business Environment Ratings
    Risk/Reward Ratings Methodology
    Ratings Overview
    Table: Pharmaceutical Business Environment Indicators
    Weighting
    Table: Weighting Of Components

SOURCES
Skip to top


The Pharmaceutical Market: Ukraine US$ 1,295.00 Jan, 2013 · 100 pages

Ask Your Question

The Pharmaceutical Market: USA
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: